What Researchers Did
Researchers reviewed the current knowledge and therapeutic applications of hyperbaric oxygen therapy in ophthalmology.
What They Found
The review found increasing evidence supporting the safety and efficacy of hyperbaric oxygen therapy for several eye conditions. These include retinal artery occlusion, cystoid macular edema secondary to retinal vein occlusion, scleral thinning, orbital rhino-cerebral mucormycosis, nonhealing corneal edema, and anterior segment ischemia.
What This Means for Canadian Patients
Canadian patients with certain acute or chronic eye disorders might benefit from hyperbaric oxygen therapy, especially for conditions like retinal artery occlusion or nonhealing corneal edema. While currently an off-label treatment for eye diseases, its potential efficacy suggests it could become a more recognized option in the future.
Canadian Relevance
This review article has no direct Canadian connection as it was not conducted in Canada or by Canadian researchers.
Study Limitations
As a review, this study summarizes existing evidence without presenting new primary research data or clinical trial outcomes.